You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • THU0437 Secukinumab for The Treatment of Psoriatic Arthritis: Comparative Effectiveness Results versus Licensed Biologics and Apremilast from A Network Meta-Analysis

Article metrics

Article menu
Download PDFPDF
Poster Presentations
Psoriatic arthritis
THU0437 Secukinumab for The Treatment of Psoriatic Arthritis: Comparative Effectiveness Results versus Licensed Biologics and Apremilast from A Network Meta-Analysis

 

Online download statistics by month:

Online download statistics by month: July 2016 to March 2024

AbstractFullPdf
Jul 2016300
Aug 2016502
Sep 2016703
Oct 20162603
Nov 20163006
Dec 20162806
Jan 20172606
Feb 20173109
Mar 20171806
Apr 20175308
May 20173904
Jun 20177209
Jul 201740010
Aug 20175808
Sep 20175004
Oct 201784012
Nov 20172601
Dec 20174000
Jan 20184203
Feb 20182400
Mar 20184601
Apr 20185206
May 20183001
Jun 20182602
Jul 20182800
Aug 20182601
Sep 20183002
Oct 20184201
Nov 20182202
Dec 20184200
Jan 2019801
Feb 2019900
Mar 20192401
Apr 20191100
May 20191901
Jun 20191301
Jul 20191801
Aug 20191801
Sep 2019600
Oct 20191400
Nov 2019501
Dec 2019400
Jan 2020801
Feb 2020300
Mar 20201300
Apr 2020702
May 2020800
Jun 20201002
Jul 20201500
Sep 20201700
Oct 2020300
Nov 2020500
Dec 2020400
Jan 2021900
Feb 2021300
Apr 20212000
May 2021100
Jul 2021100
Sep 2021001
Oct 2021200
Nov 2021400
Dec 2021800
Jan 2022400
Feb 2022400
Mar 20221501
Apr 2022800
May 20222000
Jun 2022800
Jul 2022600
Aug 2022600
Sep 2022400
Oct 20221000
Nov 20221100
Dec 20221000
Jan 2023800
Feb 2023900
Mar 2023501
Apr 2023200
May 2023400
Jun 2023300
Jul 2023200
Aug 2023501
Sep 2023800
Dec 20232602
Jan 20241000
Feb 2024200
Mar 2024400
Total15300134